Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis

被引：17
|
作者：
Asahina, Akihiko [1 ]
Ishii, Norihisa [3 ]
Tohma, Shigeto [2 ]
机构：
[1] Natl Hosp Org Sagamihara Natl Hosp, Dept Dermatol, Minami Ku, Sagamihara, Kanagawa 2520392, Japan
[2] Natl Hosp Org Sagamihara Natl Hosp, Dept Rheumatol, Sagamihara, Kanagawa 2520392, Japan
[3] Natl Inst Infect Dis, Leprosy Res Ctr, Tokyo, Japan
来源：
JOURNAL OF DERMATOLOGY | 2012年 / 39卷 / 02期
关键词：
THERAPY;
D O I：
10.1111/j.1346-8138.2011.01243.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：199 / 201
页数：3
相关论文
共 50 条
  • [31] Rheumatoid arthritis and tumor necrosis factor α
    Abe, T
    Takeuchi, T
    [J]. AUTOIMMUNITY, 2001, 34 (04) : 291 - 303
  • [32] Tumor Necrosis Factor-α Inhibitor-induced Antiglomerular Basement Membrane Antibody Disease in a Patient with Rheumatoid Arthritis
    Nishimura, Keisuke
    Saegusa, Jun
    Kawano, Seij
    Morinobu, Akio
    [J]. JOURNAL OF RHEUMATOLOGY, 2012, 39 (09) : 1904 - 1906
  • [33] Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study
    Desai, Rishi J.
    Solomon, Daniel H.
    Schneeweiss, Sebastian
    Danaei, Goodarz
    Liao, Katherine P.
    Kim, Seoyoung C.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 213 - 214
  • [34] Discontinuation of TNFi Treatment Among Rheumatoid Arthritis Patients with a Molecular Signature of Non-response to Tumor Necrosis Factor-α Inhibitor Therapies
    Curtis, Jeffrey
    Kremer, Joel
    Pappas, Dimitrios
    Zhang, Lixia
    Connolly-Strong, Erin
    Withers, Johanna
    Akmae, Viatcheslav
    Saleh, Alif
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2589 - 2590
  • [35] Serum anti-Mullerian hormone levels in women with rheumatoid arthritis during tumor necrosis factor-α inhibitor treatment: Exploratory research
    Isojima, Sakiko
    Miura, Yoko
    Saito, Mayu
    Yajima, Nobuyuki
    Miwa, Yusuke
    Kasama, Tsuyoshi
    [J]. OBSTETRIC MEDICINE, 2019, 12 (04) : 186 - 189
  • [36] Anti-tumor necrosis factor-α monoclonal antibody therapy for rheumatoid arthritis
    Kavanaugh, AF
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1998, 24 (03) : 593 - +
  • [37] Interleukin 1 or tumor necrosis factor-α:: Which is the real target in rheumatoid arthritis?
    Dayer, JM
    [J]. JOURNAL OF RHEUMATOLOGY, 2002, 29 : 10 - 15
  • [38] Graves' Disease, Rheumatoid Arthritis, and Anti-Tumor Necrosis Factor-α Therapy
    Shin, Jae Il
    Kim, Min Jung
    Lee, Jae Seung
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (02) : 449 - 450
  • [39] Tumor necrosis factor-α microsatellite polymorphism association with rheumatoid arthritis in Indian patients
    Agrawal, C
    Raghav, SK
    Gupta, B
    Das, RH
    Chaturvedi, VP
    Goswami, K
    Das, HR
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2005, 36 (05) : 555 - 559
  • [40] High Body Mass Index Shortens Retention of Tumor Necrosis Factor-α Blocker Treatment in Rheumatoid Arthritis
    Elkayam, Ori
    Lidar, Merav
    Reitblat, Tatiana
    Zisman, Devy
    Balbir-Gurman, Alexandra
    Kakakian, Odelia
    Meshiach, Tanya
    Almog, Ronit
    Elalouf, Ofir
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345